United Orthopedic Cash Flow Conversion Efficiency
United Orthopedic cash flow conversion efficiency. Based on the latest financial reports, United Orthopedic (4129) has a cash flow conversion efficiency ratio of 0.013x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$51.73 Million ≈ $1.63 Million USD) by net assets (NT$4.01 Billion ≈ $126.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of United Orthopedic (2015–2025)
Cash flow conversion efficiency of United Orthopedic from 2015 to 2025. This chart illustrates how United Orthopedic's cash flow conversion efficiency has evolved over time, based on yearly financial data. View United Orthopedic (4129) stock price for real-time trading data and today's change.
United Orthopedic Cash Flow Conversion Ratio Explained
United Orthopedic cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
United Orthopedic Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of United Orthopedic ranked by their cash flow conversion efficiency. Also see United Orthopedic stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alliance Entertainment Holding Corporation Class A Common Stock
NASDAQ:AENT
|
-0.077x |
|
Eugene Inv&Sec
KO:001200
|
-0.384x |
|
SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZ
|
-0.046x |
|
GBank Financial Holdings Inc. Common Stock
NASDAQ:GBFH
|
-0.058x |
|
CHINA RENAISSANCE HLDGS
F:6RN
|
N/A |
|
Mount Gibson Iron Limited
F:FWQ
|
0.169x |
|
Saratoga Investment Corp
NYSE:SAR
|
-0.069x |
|
Dogan Burda Dergi Yayincilik ve Pazarlama AS
IS:DOBUR
|
0.164x |
Annual Cash Flow Conversion Efficiency for United Orthopedic (2015–2025)
The table below shows the annual cash flow conversion efficiency of United Orthopedic from 2015 to 2025. Review United Orthopedic free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.20 Billion ≈ $132.46 Million |
NT$1.03 Billion ≈ $32.32 Million |
0.244x | +34.36% |
| 2024-12-31 | NT$3.95 Billion ≈ $124.45 Million |
NT$717.29 Million ≈ $22.60 Million |
0.182x | +63.81% |
| 2023-12-31 | NT$3.59 Billion ≈ $113.23 Million |
NT$398.43 Million ≈ $12.55 Million |
0.111x | +0.51% |
| 2022-12-31 | NT$3.09 Billion ≈ $97.35 Million |
NT$340.79 Million ≈ $10.74 Million |
0.110x | -7.03% |
| 2021-12-31 | NT$2.82 Billion ≈ $88.87 Million |
NT$334.64 Million ≈ $10.54 Million |
0.119x | -27.95% |
| 2020-12-31 | NT$2.93 Billion ≈ $92.15 Million |
NT$481.65 Million ≈ $15.17 Million |
0.165x | -1.89% |
| 2019-12-31 | NT$2.93 Billion ≈ $92.43 Million |
NT$492.45 Million ≈ $15.51 Million |
0.168x | +2943.61% |
| 2018-12-31 | NT$2.25 Billion ≈ $70.90 Million |
NT$12.41 Million ≈ $390.98K |
0.006x | +321.95% |
| 2017-12-31 | NT$2.22 Billion ≈ $69.88 Million |
NT$2.90 Million ≈ $91.33K |
0.001x | -98.68% |
| 2016-12-31 | NT$1.80 Billion ≈ $56.76 Million |
NT$179.03 Million ≈ $5.64 Million |
0.099x | -30.29% |
| 2015-12-31 | NT$1.77 Billion ≈ $55.86 Million |
NT$252.75 Million ≈ $7.96 Million |
0.143x | -- |
About United Orthopedic
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee… Read more